Effects of motilitone on the improvement of dyspeptic symptoms in patients with depression and anxiety disorder comorbid with dyspepsia
- Conditions
- Mental and behavioral disorders
- Registration Number
- KCT0004973
- Lead Sponsor
- Wonkwang University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 50
19 to 70 years old.
- Patients diagnosed with depression or anxiety disorder by a psychiatrist (DSM5 diagnosis criteria)
- Patients diagnosed with functional indigestion by a gastrointestinal surgeon (Rome IV createria)
- Patients whose substrate gastrointestinal diseases have been identified through gastroscopy
- A person who has undergone surgery that can affect gastrointestinal motion or a patient with a history of gastrointestinal surgery
- Patients who do not understand the purpose of this study
- Patients who have participated in a gastrointestinal drug clinical trial within the last three months
- Pregnant women, breastfeeding women and women in childbearing age who do not use proper contraception methods
- use of benzodiazepines, sleeping fill, etc. is permitted under conditions of constant capacity during clinical trials.
- Serious active medical conditions that may affect the quality of life scale are excluded. These include thyroid and adrenal cortical holmon diseases, consumptive or infectious diseases, active cancer diseases, chronic rheumatoid and autoimmune diseases, hepatitis and liver cirrhosis, acute heart failure or myocardial infarction, and acute respiratory diseases.
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method epean Dyspepsia Index(NDI) Questionnaire
- Secondary Outcome Measures
Name Time Method Overall treatment effect(OTE) Index;Sheehan Disability Scale Index;Gastric Emptying Index